Приказ основних података о документу

dc.creatorŽivanović, Marija
dc.creatorSelaković, Milica
dc.creatorSelaković, Života
dc.creatorPavić, Aleksandar
dc.creatorGrahovac, Jelena
dc.creatorŠolaja, Bogdan A.
dc.creatorSrdić-Rajić, Tatjana
dc.date.accessioned2022-12-16T15:02:22Z
dc.date.available2022-12-16T15:02:22Z
dc.date.issued2022
dc.identifier.issn0959-8049
dc.identifier.urihttp://cherry.chem.bg.ac.rs/handle/123456789/5695
dc.language.isoensr
dc.publisherElseviersr
dc.relation01-2019-F65sr
dc.relation6056979sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceEuropean Journal of Cancersr
dc.title322 (PB102) - Cationic amphiphilic drugs as potential anticancer therapy for PDACsr
dc.typeconferenceObjectsr
dc.rights.licenseBYsr
dc.citation.volume174S1
dc.citation.issuePB102
dc.citation.spageS114
dc.identifier.doi10.1016/S0959-8049(22)01106-6
dc.description.otherPart of special issue: 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona, Spain 28 October 2022 10:00–15:00: POSTER SESSION: Drug Screeningsr
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttp://cherry.chem.bg.ac.rs/bitstream/id/32053/ENA-2022-prilog.pdf


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу